Skip Navigation

European Heart Journal 2000 21(2):116-124; doi:10.1053/euhj.1999.1741
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (46)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kristal-Boneh, E.
Right arrow Articles by Froom, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kristal-Boneh, E.
Right arrow Articles by Froom, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study)

E. Kristal-Boneha,f1, H. Silberb,c, G. Hararia and P. Frooma,b

a Epidemiology Unit, Occupational Health and Rehabilitation Institute, Raanana
b Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
c Department of Cardiology, Meir Hospital, Kfar Saba, Israel

revised May 25, 1999; accepted May 26, 1999

Abstract

Background Resting heart rate has frequently been shown to be a predictor of coronary heart disease mortality. Elevated heart rate could also be a marker for the presence of other risk factors, which have not been taken into consideration in previous studies.

Objective To evaluate the effect of resting heart rate on the risk of all-cause cardiovascular and cancer mortality, taking into consideration haematological variables.

Method The association between resting heart rate and mortality was assessed applying Cox's proportional hazard models to data obtained in an 8 year follow-up of 3527 Israeli male industrial employees. During this period 135 deaths were recorded, 57 from cardiovascular disease and 45 from cancer. Resting heart rate was assessed at entry; potential confounding demographic, anthropometric and socioeconomic variables, haematological data, serum lipid levels and health-related habits were accounted for.

Results We found that the relative risk of all-cause mortality increased with increasing resting heart rate, workers with resting heart rate >90 beats.min–1had an adjusted relative risk of 2·23 (95%CI 1·4–3·6) compared with those with a heart rate <70 beats.min–1. A similar result was achieved for cardiovascular disease mortality (adjusted relative risk 2·02, 95%CI 1·1–4·0). Cancer mortality was not associated with resting heart rate.

Conclusion This study found that resting heart rate is associated with all-cause and cardiovascular disease mortality after controlling (in various statistical models) for platelet counts, haemoglobin concentration, white blood cell counts, total protein, and other recognized risk factors.

Key Words: Heart rate, mortality, cardiovascular disease, cancer, epidemiology, haematology

f1 Correspondence: Dr E. Kristal-Boneh, Rotshild Street 15/1, Kfar Saba 44449, Israel

References

  1. Dyer AR, Persky V, Stamler J. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic Studies. Am J Epidemiol. 1980;112:736–749[Abstract/Free Full Text]
  2. Schroll M, Hagerup LM. Risk factors of myocardial infarction and death in man aged 50 at entry. Dan Med Bull. 1977;24:252–255[Web of Science][Medline]
  3. Medalie JH, Kahn HA, Neufeld HN. Five-year myocardial infarction incidence. II. Association of single variables to age and birth place. J Chronic Dis. 1973;26:329–349[CrossRef][Web of Science]
  4. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18 year follow-up. Section 30. Kannel WB, Gordon T. The Framingham Study—an Epidemiological Investigation of the Cardiovascular Diseases. Washington, DC: DHEW; 1974.
  5. Friedman GD, Klatsky AL, Siegelaub AB. Predictors of sudden cardiac death. Circulation. 1975;5:164–169
  6. Kannel WB, Kannel C, Paffenbarger RS, Cupples A. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 1987;113:1489–1494[CrossRef][Web of Science][Medline]
  7. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J. 1991;121:172–177[CrossRef][Web of Science][Medline]
  8. Manuck SB, Garland FN. Stability of individual differences in cardiovascular reactivity: A Thirteen month follow-up. Physiol Behav. 1980;24:621–624[CrossRef][Medline]
  9. Steinhaus AH. Chronic effects of exercise. Physiol Rev. 1933;13:103[Free Full Text]
  10. Goldbourt U, Medalie JH. Characteristics of smokers, non-smokers and ex-smokers among 10000 adult males in Israel. II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol. 1977;105:75–86[Abstract/Free Full Text]
  11. Blackburn H, Brozek J, Taylor HL, Keys A. Comparison of cardiovascular and related characteristics in habitual smokers and non-smokers. Ann N Y Acad Sci. 1960;90:277–289[CrossRef][Web of Science]
  12. Higgins MW, Kjelsberg M. Characteristics of smokers and non-smokers in Tecumseh, Michigan. II The distribution of selected physical measurements and physiologic variables and the prevalence of certain diseases in smokers and non-smokers. Am J Epidemiol. 1967;86:60–77[Free Full Text]
  13. Thomas CB. Characteristics of smokers compared with non-smokers in a population of healthy young adults, including observations of family history, blood pressure, heart rate, body weight, cholesterol and certain physiologic traits. Ann Intern Med. 1960;53:697–718[Abstract/Free Full Text]
  14. Gillum RF. The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am Heart J. 1988;116:163–174[CrossRef][Web of Science][Medline]
  15. Haddy FJ. Local control of vascular resistance as related to hypertension. Arch Intern Med. 1974;133:916[Abstract/Free Full Text]
  16. Dimsdale JE, Herd JA. Variability of plasma lipids in response to emotional arousal (review article). Psychosom Med. 1982;44:413–430[Abstract/Free Full Text]
  17. Golding L. Effects of physical training upon total serum cholesterol levels. Res Quart. 1961;32:499
  18. Skinner JS, Holloszy KO, Cureton TK. Effects of a program of endurance exercises on physical work. Am J Cardiol. 1964;14:747[CrossRef][Web of Science][Medline]
  19. Ohlsson O, Henningsen NC, Malmquist I. Blood pressure, heart rate and plasma albumin in relatives of hypertensive patients. Acta Med Scand. 1981;209:445–450[Web of Science][Medline]
  20. Tibblin G, Bergrntz SE, Bjure J. Hematocrit, plasma protein, plasma volume, and viscosity in early hypertensive disease. Am Heart J. 1966;72:165–176[CrossRef][Web of Science][Medline]
  21. Chang-Yeung M, Buncio AD. Leokocyte count, smoking, and lung function. Am J Med. 1984;76:31–37[CrossRef][Web of Science][Medline]
  22. Friedman GD, Siegelaub AB, Seltzer CC, Feldman R, Collen MF. Smoking habits and the leukocyte count. Arch Environ Health. 1973;26:137–143[Web of Science][Medline]
  23. Kristal-Boneh E, Harari G, Green MS. Serum lipids and haematological factors associated with resting heart rate: the CORDIS Study. J Cardio Risk. 1994;1:59–67
  24. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361662 men. Lancet. 1986;ii:933–936
  25. JAMA. 1984;251:365–374[Abstract/Free Full Text]
  26. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer and other causes. Lancet. 1989;ii:1434–1436
  27. Kuller LH, Eichner JE, Orchard TJ, Grandits GA, McCallum L, Russell PT. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1991;134:1266–1277[Abstract/Free Full Text]
  28. Birnbaum M. Normal hemoglobin level and coronary heart disease. Am Heart J. 1963;62:136–137
  29. Burch G, DePasquale N. Erythrocytosis and ischemic myocardial disease. Am Heart J. 1963;62:139–140
  30. Abu-Zeid HAH, Chapman JM. The relationship between hemoglobin level and some risk factors in ischemic heart disease. The Los Angeles Heart Study [abstract]. Circulation. 1973;48:9[Free Full Text]
  31. Fagher B, Sjogren A, Sjogren U. Platelet counts in myocardial infarction, angina pectoris and peripheral artery disease. Acta Med Scand. 1985;271:21–26
  32. Ensrud K, Grimm RH. The white blood cell count and risk for coronary heart disease. Am Heart J. 1992;124:207–213[CrossRef][Web of Science][Medline]
  33. Thaulow E, Erikssen J, Sandvik L, Cohn PF. Blood platelet count is related to cardiovascular death in apparently healthy men [abstract]. Circulation. 1989;80:II299
  34. Wannamethee G, Shaper AG, Macfarlane PW. Heart rate, physical activity, and mortality from cancer and other noncardiovascular diseases. Am J Epidemiol. 1993;137:735–748[Abstract/Free Full Text]
  35. Persky V, Dyer AR, Leonas J. Heart rate a risk factor for cancer? Am J Epidemiol. 1981;114:477–487[Abstract/Free Full Text]
  36. Garcia-Palmieri MR, Sorlie PD, Costas R Jr. An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico. Am J Epidemiol. 1981;114:29–40[Abstract/Free Full Text]
  37. Severson RK, Nomura AMY, Grove JS. A prospective analysis of physical activity and cancer. Am J Epidemiol. 1989;130:522–529[Abstract/Free Full Text]
  38. Gann PH, Daviglus ML, Dyer AR, Stamler J. Heart rate and prostate cancer mortality: Results of a prospective analysis. Cancer Epidemiol Bio Prev. 1995;4:611–616[Abstract]
  39. Lee IM, Paffenbarger RS Jr, Hsieh CC. Physical activity and risk of prostatic cancer among college alumni. Am J Epidemiol. 1992;135:169–179[Abstract/Free Full Text]
  40. Green M, Peled I. Prevalence and control of hypertension in a large cohort of occupationally-active Israelis examined during 1985–1987. The CORDIS Study. Int J Epidemiol. 1992;21:676–682[Abstract/Free Full Text]
  41. Allain CC, Poon IS, Chan CSG, Richmond IY, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–475[Abstract]
  42. Kristal-Boneh E, Harari G, Weinstein Y, Green MS. Factors affecting differences in supine, sitting, and standing heart rate: the Israeli CORDIS study. Aviat Space Environ Med. 1995;66:775–779[Medline]
  43. SAS Institute Inc, SAS Language: Reference, Cary, NC, SAS Institute Inc
  44. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens. 1997;15:3–17[CrossRef][Web of Science][Medline]
  45. Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Corcoran lecture. Hypertension. 1993;21:886–893[Free Full Text]
  46. Conway J. Hemodynamic aspects of essential hypertension in humans. Physiol Rev. 1984;64:617–660[Free Full Text]
  47. Ewing DJ, Campbell IW, Clarke BF. Heart rate changes in diabetes mellitus. Lancet. 1981;1:183–185[CrossRef][Web of Science][Medline]
  48. Gordon D, Guyton I, Karnovsky N. Intimal alterations in rat aorta induced by stressful stimuli. Lab Invest. 1983;45:14–19
  49. Hirsch EZ, Maksem JA, Gagen D. Effects of stress and propanolol on the aortic intima of rats (Abstr). Arteriosclerosis. 1984;4:526
  50. Persky A, Hamsten A, Lindvall K, Theorell T. Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients. Am Heart J. 1988;116:1360–1373
  51. Persky A, Olsson G, London C, deFaire U, Theorell T, Hamsten A. Minimum heart rate and coronary atherosclerosis. Independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J. 1992;123:609–616[CrossRef][Web of Science][Medline]
  52. Malik M, Camm J. Clinical implications and use of heart rate variability. Malik M, Camm J. Heart rate variability (part IV). New York: Futura Pub. Comp. Inc; 1995. p. 331–338

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Circ Cardiovasc GenetHome page
F. Marroni, A. Pfeufer, Y. S. Aulchenko, C. S. Franklin, A. Isaacs, I. Pichler, S. H. Wild, B. A. Oostra, A. F. Wright, H. Campbell, et al.
A Genome-Wide Association Scan of RR and QT Interval Duration in 3 European Genetically Isolated Populations: The EUROSPAN Project
Circ Cardiovasc Genet, August 1, 2009; 2(4): 322 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
R. Ferrari
A step further with ivabradine: SIGNIfY (Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease)
Eur. Heart J. Suppl., August 1, 2009; 11(suppl_D): D19 - D27.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
B. Olshansky, R. Gopinathannair, and R. M. Sullivan
DAVID II did not slay Goliath.
J. Am. Coll. Cardiol., March 10, 2009; 53(10): 881 - 883.
[Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
J.-C. Tardif
The pivotal role of heart rate in clinical practice: from atherosclerosis to acute coronary syndrome
Eur. Heart J. Suppl., August 1, 2008; 10(suppl_F): F11 - F16.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
T. W. Hansen, L. Thijs, J. Boggia, Y. Li, M. Kikuya, K. Bjorklund-Bodegard, T. Richart, T. Ohkubo, J. Jeppesen, C. Torp-Pedersen, et al.
Prognostic Value of Ambulatory Heart Rate Revisited in 6928 Subjects From 6 Populations
Hypertension, August 1, 2008; 52(2): 229 - 235.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
R. Kolloch, U. F. Legler, A. Champion, R. M. Cooper-DeHoff, E. Handberg, Q. Zhou, and C. J. Pepine
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST)
Eur. Heart J., May 2, 2008; 29(10): 1327 - 1334.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
N. Spielmann, A. S. Leon, D. C. Rao, T. Rice, J. S. Skinner, T. Rankinen, and C. Bouchard
Genome-wide linkage scan for submaximal exercise heart rate in the HERITAGE family study
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3366 - H3371.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. D. Paterson, B. N. Rutledge, P. A. Cleary, J. M. Lachin, R. S. Crow, and for the Diabetes Control and Complications Trial/E
The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
Diabetes Care, August 1, 2007; 30(8): 2107 - 2112.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
N. Chaowalit, R. B. McCully, M. J. Callahan, F. Mookadam, K. R. Bailey, and P. A. Pellikka
Outcomes after normal dobutamine stress echocardiography and predictors of adverse events: long-term follow-up of 3014 patients
Eur. Heart J., December 2, 2006; 27(24): 3039 - 3044.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. Cook, M. Togni, M. C. Schaub, P. Wenaweser, and O. M. Hess
High heart rate: a cardiovascular risk factor?
Eur. Heart J., October 2, 2006; 27(20): 2387 - 2393.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
K. P. Savonen, T. A. Lakka, J. A. Laukkanen, P. M. Halonen, T. H. Rauramaa, J. T. Salonen, and R. Rauramaa
Heart rate response during exercise test and cardiovascular mortality in middle-aged men
Eur. Heart J., March 1, 2006; 27(5): 582 - 588.
[Abstract] [Full Text] [PDF]

Home page
 J. Epidemiol. Community HealthHome page
J.-B. Ruidavets, S. Cassadou, M. Cournot, V. Bataille, M. Meybeck, and J. Ferrieres
Increased resting heart rate with pollutants in a population based study
J Epidemiol Community Health, August 1, 2005; 59(8): 685 - 693.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Diaz, M. G. Bourassa, M.-C. Guertin, and J.-C. Tardif
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease
Eur. Heart J., May 2, 2005; 26(10): 967 - 974.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. Roach, W. Wilson, D. Ritchie, and R. Sheldon
Dissection of long-range heart rate variability: Controlled induction of prognostic measures by activity in the laboratory
J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2271 - 2277.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
L. J. Martin, A. G. Comuzzie, G. E. Sonnenberg, J. Myklebust, R. James, J. Marks, J. Blangero, and A. H. Kissebah
Major Quantitative Trait Locus for Resting Heart Rate Maps to a Region on Chromosome 4
Hypertension, May 1, 2004; 43(5): 1146 - 1151.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
K. Fox
Ivabradine -- a selective and specific If inhibitor: efficacy and safety in stable angina
Eur. Heart J. Suppl., September 1, 2003; 5(suppl_G): G36 - G45.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
C. M. O'Connor, W. A. Gattis, K. F. Adams Jr, V. Hasselblad, B. Chandler, A. Frey, I. Kobrin, M. Rainisio, M. R. Shah, J. Teerlink, et al.
Tezosentan in patients with acuteheart failure and acute coronary syndromes: Results of the randomized intravenous tezosentan study (ritz-4)
J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1452 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Torre-Amione, J.-B. Durand, S. Nagueh, M. T. Vooletich, I. Kobrin, and C. Pratt
A Pilot Safety Trial of Prolonged (48 h) Infusion of the Dual Endothelin-Receptor Antagonist Tezosentan in Patients With Advanced Heart Failure
Chest, August 1, 2001; 120(2): 460 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
W. Kannel
On checking the pulse
Eur. Heart J., January 2, 2000; 21(2): 97 - 98.
[PDF]

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (46)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kristal-Boneh, E.
Right arrow Articles by Froom, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kristal-Boneh, E.
Right arrow Articles by Froom, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?